These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18321198)

  • 1. Preliminary study of the effect of FK506 nanospheric-suspension eye drops on rejection of penetrating keratoplasty.
    Fei WL; Chen JQ; Yuan J; Quan DP; Zhou SY
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):235-44. PubMed ID: 18321198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
    Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
    Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y
    Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft].
    Shi WY; Liu T; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):299-304. PubMed ID: 16762204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus-loaded methoxy poly(ethylene glycol)-block-poly(D,L)-lactic-co-glycolic acid micelles self-assembled in aqueous solution for treating cornea immune rejection after allogenic penetrating keratoplasty in rats.
    Liu D; Wu Q; Chen W; Lin H; Liu Y; Liang H; Zhu F
    Eur J Pharm Sci; 2019 May; 133():104-114. PubMed ID: 30928512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The study of FK506 eye drops preventing and treating immune rejection on limbal allograft transplantation].
    Chen J; Zhou Q; Zeng J; Xu JT; Zhao SB; Wang YP
    Zhonghua Yan Ke Za Zhi; 2003 Sep; 39(9):550-4. PubMed ID: 14766087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat.
    Nishi M; Herbort CP; Matsubara M; Morishita Y; Nishimura M; Nieda M; Mori S; Mochizuki M
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2477-86. PubMed ID: 7686893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK-506 delays corneal graft rejection in a model of corneal xenotransplantation.
    Benelli U; Lepri A; Del Tacca M; Nardi M
    J Ocul Pharmacol Ther; 1996; 12(4):425-31. PubMed ID: 8951679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration.
    Yuan J; Zhai JJ; Chen JQ; Ye CT; Zhou SY
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):345-50. PubMed ID: 19492954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
    Shi W; Gao H; Xie L; Wang S
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical FK-506 prevents experimental corneal allograft rejection.
    Mills RA; Jones DB; Winkler CR; Wallace GW; Wilhelmus KR
    Cornea; 1995 Mar; 14(2):157-60. PubMed ID: 7538061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental studies on the effect of the immunosuppressant FK-506 on penetrating keratoplasty rejection model in rats].
    Lü L; Zhang W; Sun X
    Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):25-8. PubMed ID: 11835769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of FK 506 on the cornea: use of topical FK 506 in corneal transplantation in a guinea pig-rat model.
    Tchah H; Lim B
    Korean J Ophthalmol; 1999 Dec; 13(2):71-7. PubMed ID: 10761401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of corneal graft rejection by subconjunctival injection of FK-506 in a rat model of penetrating keratoplasty.
    Minamoto A; Sakata H; Okada K; Fujihara M
    Jpn J Ophthalmol; 1995; 39(1):12-9. PubMed ID: 7543958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of FK506 ointment (Protopic) on rat skin allograft model.
    Kim YE; Eun SC
    Transplant Proc; 2014 May; 46(4):1222-5. PubMed ID: 24815165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tissue distribution of tacrolimus (FK506) after a single or repeated ocular instillation in rabbits.
    Fujita E; Teramura Y; Shiraga T; Yoshioka S; Iwatsubo T; Kawamura A; Kamimura H
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):309-19. PubMed ID: 18476801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection.
    Gebhardt BM; Varnell ED; Kaufman HE
    J Ocul Pharmacol Ther; 1995; 11(4):509-17. PubMed ID: 8574814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the TLR2/MyD88/NF-κB axis on corneal allograft rejection after penetrating keratoplasty.
    Wu W; Yu S; Feng S; Yang J; Lu X
    J Recept Signal Transduct Res; 2016; 36(1):45-52. PubMed ID: 25800037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
    Zhang T; Li Z; Liu T; Li S; Gao H; Wei C; Shi W
    PLoS One; 2018; 13(5):e0196571. PubMed ID: 29734357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of anti-CD25 monoclonal antibody on the level of cytokines in aqueous humour after rat penetrating keratoplasty].
    Gong YB; Lu XH; Ke XY; Zhou J; Yuan W; Tang MF; Luo XY; Cui GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1523-9. PubMed ID: 18819859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.